ALX Oncology Holdings Inc. (ALXO) Stock

ALX Oncology Holdings Inc. (ALXO) is a Healthcare stock trading at $1.54 (as of 2026-06-18), with a market capitalization of $224.72M and a trailing P/E of -1.1. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

ALX Oncology Holdings Inc. develops immuno-oncology therapies for cancer patients. Its lead candidate, ALX148, is a CD47-blocking therapeutic in Phase 1b/2 for myelodysplastic syndromes and in trials for acute myeloid leukemia, non-Hodgkin’s lymphoma, and several solid tumors; it also has a preclinical program including ALTA-002, a SIRPa TRAAC.

Valuation — source: SEC EDGAR (first-party)
Price$1.54
Market Cap$224.72M
P/E Ratio-1.1
EV / EBITDA-2.1
Price / Book1.40
Price / Sales58.04
DCF Value (model)$-10.86
DCF Upside vs Price-805.2%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$3.96M
Net Margin-2565.5%
Return on Equity-58.7%
Debt / Equity0.06
Current Ratio7.21
Revenue Growth (YoY)-57.7%
EPS Growth (YoY)-26.4%
FCF Growth (YoY)-31.1%
Financial Health — source: SEC EDGAR
Altman Z-Score-18.67 (distress)
Valuation vs Sector & Industry
Stock P/E-1.1
Sector P/E (Healthcare)20.9
Industry P/E (Pharmaceutical Products)17.0
vs Sector-105.1%
vs Industry-106.2%
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional HolderTCG Crossover Management, LLC ($26.09M)
Institutional Holders Tracked10
Company
SectorHealthcare
IndustryPharmaceutical Products
CEOJason W. Lettmann
Employees65
CountryUS
IPO Date2020-07-17

Related Companies (Business model: Biotech (Clinical / Commercial-Stage); 8 closest by market cap; US-domiciled)

  • MediciNova, Inc. (MNOV)
  • Voyager Acquisition Corp. (VACH)
  • MIRA Pharmaceuticals, Inc. (MIRA)
  • Clene Inc. (CLNN)
  • Metagenomi, Inc. Common Stock (MGX)
  • Cumberland Pharmaceuticals Inc. (CPIX)
  • MAIA Biotechnology, Inc. (MAIA)
  • Aligos Therapeutics, Inc. (ALGS)
ALXO earnings history · ALXO institutional & insider holders · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.